Ph1 INCB123667 Mono & Combo w/ Anticancer Therapies in Solid Tumors
Phase I Clinical Trial
A Phase 1 Open-Label Multicenter Study of INCB123667 as Monotherapy and in Combination With Anticancer Therapies in Participants With Selected Advanced Solid Tumors (INCB 123667-101)